Interact to see
Advertisement
Advertisement
ADNRX vs PAMCX
ADNRX vs PAMCX Comparison
Open Charts ADNRX vs PAMCX
American Beacon ARK Transfmt Innov R6
Price$22.25
Change+$0.70 (+3.25%)
VolumeN/A
Net Assets209.58M
T. Rowe Price Mid-Cap Growth Adv
Price$97.57
Change+$0.86 (+0.89%)
VolumeN/A
Net Assets25.6B
ADNRX vs PAMCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. PAMCX commentary
Dec 04, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and PAMCX is a Buy.
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 25.6B vs. ADNRX (210M). ADNRX (0.00) and PAMCX (0.00) have matching dividends . ADNRX was incepted earlier than PAMCX: ADNRX (5 years) vs PAMCX (26 years). ADNRX (1.13) is less costly to investors than PAMCX (1.01). ADNRX is a more actively managed with annual turnover of: 46.00 vs. PAMCX (22.60). ADNRX has a lower initial minimum investment than PAMCX: ADNRX (0) vs PAMCX (2500). ADNRX annual gain was more profitable for investors over the last year : 31.21 vs. PAMCX (-11.87). PAMCX return over 5 years is better than : -11.47 vs. ADNRX (-49.08).
| ADNRX | PAMCX | ADNRX / PAMCX | |
| Total Expense Ratio | 1.00 | 1.01 | 99% |
| Annual Report Gross Expense Ratio | 1.13 | 1.01 | 112% |
| Fund Existence | 5 years | 26 years | - |
| Gain YTD | 37.267 | 3.054 | 1,220% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 210M | 25.6B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 31.21 | -11.87 | -263% |
| Returns for 3 years | 88.71 | 5.68 | 1,563% |
| Returns for 5 years | -49.08 | -11.47 | 428% |
| Returns for 10 years | N/A | 21.60 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement